However, we aimed to further understand if there was a correlation between loss of lymphocytes, either CD3+ , CD4 + or CD8 + T-cells in the day-20 On-treatment tumour biopsy and a reduction in tumour volume in the biopsy (Fig. 5). The gene discussed is CD4; the disease is neoplasm.